PAC-1 (Procaspase activating compound 1) has been used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others.
Molecular Weight:
392.49
Purity:
96.78%
CAS Number:
[315183-21-2]
Formula:
C23H28N4O2
Target:
Caspase|||Autophagy|||Apoptosis
T2503
* VAT and and shipping costs not included. Errors and price changes excepted